Raphaël Steiner

2.5k total citations
63 papers, 577 citations indexed

About

Raphaël Steiner is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Raphaël Steiner has authored 63 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 36 papers in Oncology and 16 papers in Genetics. Recurrent topics in Raphaël Steiner's work include Lymphoma Diagnosis and Treatment (38 papers), CAR-T cell therapy research (25 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Raphaël Steiner is often cited by papers focused on Lymphoma Diagnosis and Treatment (38 papers), CAR-T cell therapy research (25 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Raphaël Steiner collaborates with scholars based in United States, Switzerland and Australia. Raphaël Steiner's co-authors include Sattva S. Neelapu, Ranjit Nair, Sairah Ahmed, Loretta J. Nastoupil, Paolo Strati, Jason R. Westin, Michael Wang, Swaminathan P. Iyer, Hun Ju Lee and Misha Hawkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Raphaël Steiner

55 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphaël Steiner United States	13	406	237	114	86	74	63	577
Saurabh Dahiya United States	15	629 1.5×	203 0.9×	67 0.6×	104 1.2×	116 1.6×	105	923
Jennifer L. Crombie United States	15	421 1.0×	406 1.7×	119 1.0×	56 0.7×	277 3.7×	63	822
Paul Maciocia United Kingdom	9	378 0.9×	121 0.5×	22 0.2×	32 0.4×	32 0.4×	23	504
Emily Robinson United States	9	814 2.0×	101 0.4×	85 0.7×	191 2.2×	36 0.5×	13	1.0k
Alexandra Russo Germany	12	194 0.5×	34 0.1×	67 0.6×	29 0.3×	60 0.8×	28	490
Matthias Mulazzani Germany	9	178 0.4×	111 0.5×	75 0.7×	18 0.2×	64 0.9×	11	393
Khalifa El Malki Germany	10	215 0.5×	43 0.2×	49 0.4×	29 0.3×	44 0.6×	19	520
Ashley D. Staton United States	9	171 0.4×	107 0.5×	16 0.1×	19 0.2×	35 0.5×	20	340
Arthur Wingerter Germany	10	200 0.5×	23 0.1×	67 0.6×	29 0.3×	53 0.7×	26	419
Peter Holman United States	14	234 0.6×	96 0.4×	23 0.2×	11 0.1×	72 1.0×	72	541

Countries citing papers authored by Raphaël Steiner

Since Specialization

Citations

This map shows the geographic impact of Raphaël Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Steiner more than expected).

Fields of papers citing papers by Raphaël Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Steiner. The network helps show where Raphaël Steiner may publish in the future.

Co-authorship network of co-authors of Raphaël Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Steiner. A scholar is included among the top collaborators of Raphaël Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Steiner. Raphaël Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steiner, Raphaël, Liana Nikolaenko, Ranjit Nair, et al.. (2025). Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial. Blood Advances. 9(21). 5556–5563.

Wu, Susan, Penny Fang, Kelsey L. Corrigan, et al.. (2024). Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung. Advances in Radiation Oncology. 9(12). 101648–101648. 1 indexed citations

Steiner, Raphaël, Allison M. Bock, Alex F. Herrera, et al.. (2024). CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab. Blood. 144(Supplement 1). 4434.2–4434.2. 1 indexed citations

Marques‐Piubelli, Mario L., Do H. Kim, L. Jeffrey Medeiros, et al.. (2023). CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy. Histopathology. 83(1). 143–148. 10 indexed citations

Wu, Susan, Penny Fang, Sairah Ahmed, et al.. (2023). Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Advances in Radiation Oncology. 8(6). 101279–101279. 4 indexed citations

Corrigan, Kelsey L., Berthold Schrank, Lewis Nasr, et al.. (2023). Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract. International Journal of Radiation Oncology*Biology*Physics. 117(2). e460–e460.

Iyer, Swaminathan P., Lei Feng, Jie Xu, et al.. (2023). TCL-275 Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients With Relapsed or Refractory T-Cell Lymphoma (TCL) With Survival Analysis. Clinical Lymphoma Myeloma & Leukemia. 23. S468–S469. 3 indexed citations

Dabaja, Bouthaina S., David Boyce-Fappiano, Wenli Dong, et al.. (2022). Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience. Clinical and Translational Radiation Oncology. 35. 64–69. 1 indexed citations

Steiner, Raphaël, José Banchs, Efstratios Koutroumpakis, et al.. (2021). Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma. Haematologica. 107(7). 1555–1566. 25 indexed citations

10.

Augustyn, Alexander, Jillian R. Gunther, Penny Fang, et al.. (2020). Radiation Therapy for Refractory High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. International Journal of Radiation Oncology*Biology*Physics. 108(3). S168–S168. 2 indexed citations

11.

Mamlouk, Omar, Ranjit Nair, Swaminathan P. Iyer, et al.. (2020). Safety of CAR T-cell therapy in kidney transplant recipients. Blood. 137(18). 2558–2562. 38 indexed citations

12.

Aponte, Maria, Peter Kim, Anita Deswal, et al.. (2020). Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. SHILAP Revista de lepidopterología. 3(3). 113–120. 12 indexed citations

13.

Fang, Penny, Jillian R. Gunther, Chelsea C. Pinnix, et al.. (2020). A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1414–1420. 6 indexed citations

14.

Gunther, Jillian R., Chelsea C. Pinnix, Penny Fang, et al.. (2020). Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. SHILAP Revista de lepidopterología. 1(1). 272–276. 3 indexed citations

15.

Steiner, Raphaël, Chelsea C. Pinnix, Bouthaina S. Dabaja, et al.. (2019). An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Medicine. 9(2). 663–670. 16 indexed citations

16.

Steiner, Raphaël, Robert Z. Orlowski, & Hans C. Lee. (2018). Acute Pancreatitis Associated with Ixazomib in a Multiple Myeloma Patient. Acta Haematologica. 139(1). 67–70. 3 indexed citations

17.

Steiner, Raphaël, Jorge Romaguera, & Michael Wang. (2018). Current trials for frontline therapy of mantle cell lymphoma. Journal of Hematology & Oncology. 11(1). 13–13. 12 indexed citations

18.

Chaudhry, Maria, Raphaël Steiner, Catherine M. Claussen, et al.. (2017). Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and Waldenström's Macroglobulinemia. Blood. 130. 1880–1880. 1 indexed citations

19.

Steiner, Raphaël & Elisabet E. Manasanch. (2017). Carfilzomib boosted combination therapy for relapsed multiple myeloma. OncoTargets and Therapy. Volume 10. 895–907. 13 indexed citations

20.

Buddeberg, Claus, C. Roland Wolf, M. Sieber, et al.. (1991). Coping Strategies and Course of Disease of Breast Cancer Patients. Psychotherapy and Psychosomatics. 55(2-4). 151–157. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact